These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28011475)

  • 1. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
    Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
    Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
    Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
    Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
    Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
    Georgescu MM; Gagea M; Cote G
    Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+-H+ exchanger regulatory factor 1 (NHERF1) PDZ scaffold binds an internal binding site in the scavenger receptor megalin.
    Slattery C; Jenkin KA; Lee A; Simcocks AC; McAinch AJ; Poronnik P; Hryciw DH
    Cell Physiol Biochem; 2011; 27(2):171-8. PubMed ID: 21325834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism.
    Greco MR; Bon E; Rubino R; Guerra L; Bernabe-Garcia M; Cannone S; Cayuela ML; Ciaccia L; Marionneau-Lambot S; Oullier T; Fromont G; Guibon R; Roger S; Reshkin SJ; Cardone RA
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):26-37. PubMed ID: 30326259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na+/H+ exchanger regulatory factors (NHERFs).
    Hu Z; Hu J; Zhang Z; Shen WJ; Yun CC; Berlot CH; Kraemer FB; Azhar S
    J Biol Chem; 2013 Apr; 288(16):11416-35. PubMed ID: 23482569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite NHERF1 phosphorylation controls GRK6A regulation of hormone-sensitive phosphate transport.
    Vistrup-Parry M; Sneddon WB; Bach S; Strømgaard K; Friedman PA; Mamonova T
    J Biol Chem; 2021; 296():100473. PubMed ID: 33639163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NHERF1/EBP50 is a new marker in colorectal cancer.
    Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
    Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
    Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
    Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
    Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
    J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.
    Wheeler DS; Barrick SR; Grubisha MJ; Brufsky AM; Friedman PA; Romero G
    Oncogene; 2011 Jan; 30(1):32-42. PubMed ID: 20802536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
    Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ
    J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM
    Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in the sensitivity to crizotinib by Na
    Yang F; Hu M; Chang S; Huang J; Si Y; Wang J; Cheng S; Jiang WG
    BMC Cancer; 2020 Mar; 20(1):202. PubMed ID: 32164629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.